Elevai Labs (ELAB) announces that its wholly owned subsidiary, Elevai Skincare, has achieved a record-breaking month in sales for 2024, marking a significant milestone for the Company. This achievement underscores the success of transformational restructuring efforts led by Elevai Labs’ new executive team and the adoption of a performance-driven culture. Preliminary unaudited sales data for Elevai Skincare for November 2024 reflects revenue of $300K significantly higher than monthly figures earlier in the year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAB: